<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8531">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02995889</url>
  </required_header>
  <id_info>
    <org_study_id>308_14</org_study_id>
    <nct_id>NCT02995889</nct_id>
  </id_info>
  <brief_title>FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      This study investigates the feasibility of FLT-PET to improve the diagnosis of relapse in
      patients with irradiated lung cancer in comparison with FDG-PET/CT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2014</start_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with local and/or regional relapse</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Lung Cancer, Nonsmall Cell</condition>
  <condition>Small Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>FLT-PET</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FLT-PET</intervention_name>
    <arm_group_label>FLT-PET</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  history with lung cancer, small cell or non-small cell

          -  radiotherapy of lung cancer ended within the last 24 months

          -  radiotherapy might be normofractionated or stereotactic

          -  current suspicion of relapse

          -  written and oral consent

        Exclusion Criteria:

          -  communication difficulties

          -  pregnancy or lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Kjær, MD phD MDSci</last_name>
    <role>Study Chair</role>
    <affiliation>Dept of Clinical Physiology, Nuclear medicine and PET, Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tine N Christensen, MD</last_name>
    <phone>+45 45356352</phone>
    <email>tine.noehr.christensen.02@regionh.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Malene Fischer, MD phD MDsci</last_name>
    <phone>+45 45359824</phone>
    <email>barbara.malene.fischer@regionh.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tine N Christensen, MD</last_name>
      <phone>+45 45356352</phone>
      <email>tine.noehr.christensen.02@regionh.dk</email>
    </contact>
    <contact_backup>
      <last_name>Malene Fischer, MD phD DMSci</last_name>
      <phone>+45 45359824</phone>
      <email>barbara.malene.fischer@regionh.dk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dept. Respiratory Medicine, Bispebjerg University Hospital</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Richter, MD phD</last_name>
      <phone>+45 40261960</phone>
      <email>klaus.richter.larsen@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 16, 2016</lastchanged_date>
  <firstreceived_date>December 9, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Tine Nøhr Christensen</investigator_full_name>
    <investigator_title>MD, research fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Small Cell Lung Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
